Long-Term Debt: The sum of all long term debt fields.
Armata Pharmaceuticals, Inc. (ARMP) had Long-Term Debt of $256.92M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.08M |
|
$-124.30M |
|
-- |
|
$1.08M |
|
$14.91M |
|
$-13.82M |
|
$-110.47M |
|
$-124.30M |
|
$-124.30M |
|
$-124.30M |
|
$-124.30M |
|
$-124.30M |
|
$-124.30M |
|
$-13.82M |
|
$-13.40M |
|
36.24M |
|
36.24M |
|
$-3.43 |
|
$-3.41 |
|
| Balance Sheet Financials | |
$10.67M |
|
$12.19M |
|
$66.21M |
|
$76.88M |
|
$8.95M |
|
|
Long-Term Debt |
$256.92M |
$286.53M |
|
$295.48M |
|
$-218.60M |
|
$-222.09M |
|
$-218.60M |
|
36.43M |
|
| Cash Flow Statement Financials | |
$-25.76M |
|
$-0.54M |
|
$25.61M |
|
$14.77M |
|
$14.08M |
|
$-0.69M |
|
$2.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
6.70 |
|
-1.18 |
|
100.00% |
|
-1274.01% |
|
-1274.01% |
|
-- |
|
-11456.04% |
|
-11456.04% |
|
$-26.30M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
2.30 |
|
39.15 |
|
56.86% |
|
55.97% |
|
-161.67% |
|
-324.33% |
|
$-6.00 |
|
$-0.73 |
|
$-0.71 |
|